why choose us

First received: May 18, 2023

Clinical Trial: An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prader-Willi Syndrome

Study Type: INTERVENTIONAL


Official Title: An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

Brief Summary: A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Prader-Willi Syndrome.

Read more